Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a withholding of 936 shares of common stock on 2026-08-08 at $4.70 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units. After this tax-related disposition, Chakravarthy directly holds 583,535 shares of Enovix common stock. This balance includes 351,589 shares issuable upon vesting and settlement of RSUs, 10,393 vested PRSUs scheduled for release in March 2027, and 58,500 additional PRSUs scheduled to be released in April 2027 and April 2028.
Enovix Corp President and CEO Rajendra K. Talluri reported a Form 4 transaction involving company common stock. On 2026-08-08, 4,300 shares of common stock were disposed of at $4.70 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units. This was recorded as a payment of tax liability by delivering or withholding securities, not as an open-market sale. Following this transaction, Talluri directly held 2,958,373 shares of common stock, which includes 1,793,619 shares issuable upon vesting and settlement of RSUs, 47,775 vested PRSUs scheduled for release in March 2027, and an additional 259,611 PRSUs scheduled for releases in April 2027 and April 2028.
Enovix Corp’s Chief Operating Officer Michael Vyvoda reported equity compensation transactions in common stock. He was granted 932,400 restricted stock units (RSUs), each representing one share, vesting 25% on August 5, 2026 and the remainder in 12 quarterly installments, subject to continuous service. He also received 23,310 fully vested shares upon RSU settlement and had 13,579 shares withheld at $4.29 per share to satisfy tax withholding obligations related to RSU vesting. A portion of his reported holdings now includes the 932,400 unvested RSUs that will settle into shares over time.
Enovix Corp filed an initial Form 3 reporting that Michael Vyvoda is a reporting person in his role as Chief Operating Officer. The filing does not report any transactions or derivative positions and notes that a Power of Attorney is attached as Exhibit 24.
Enovix Corp reported that Chief Legal Officer Arthi Chakravarthy had 2,221 shares of common stock withheld on July 24, 2026 at $3.95 per share to cover tax obligations arising from vesting RSUs. After this tax-withholding disposition, Chakravarthy directly holds 584,471 shares, including 353,355 shares issuable from RSUs and multiple PRSU awards scheduled for release between March 2027 and April 2028.
BlackRock, Inc. reports beneficial ownership of common stock of Enovix Corp. As of June 30, 2026, BlackRock and certain consolidated business units beneficially owned 15,072,422 shares of Enovix common stock, representing 6.9% of the class.
BlackRock has sole voting power over 14,719,923 shares and sole dispositive power over 15,072,422 shares, with no shared voting or dispositive power. Various underlying clients and funds have rights to dividends or sale proceeds, but no individual person has an interest exceeding five percent of Enovix’s outstanding common shares.
Enovix Corp President and CEO Rajendra K. Talluri reported a tax-withholding disposition of 17,651 shares of common stock at $4.72 per share in connection with RSU vesting. After this, he beneficially owns 2,962,673 shares, including 1,801,739 RSU-based shares, 47,775 vested PRSUs, and 259,611 additional PRSUs scheduled for future release.
Enovix Corp Chief Financial Officer Ryan A. Benton reported a tax-withholding disposition of 19,824 shares of common stock on July 14, 2026. Shares were withheld at $5.06 per share to satisfy tax obligations arising from the vesting of restricted stock units. Following this withholding, Benton directly holds 894,556 shares of common stock, including 789,817 shares issuable upon future vesting and settlement of RSUs granted to him.
Enovix Corp Chief Accounting Officer Kristina Truong reported two F-code transactions in Enovix common stock. A total of 1,268 shares were withheld on July 10 and 13, 2026 to cover tax obligations upon vesting of restricted stock units, leaving her with 304,149 shares held directly.
Her direct position includes shares issuable from restricted stock units and vested performance RSUs, including 2,489 PRSUs to be released in March 2027 and 35,278 PRSUs to be released in April 2027 and April 2028.
Enovix Corp Chief Accounting Officer Kristina Truong reported a Form 4 showing a tax-related share withholding. On July 8, 2026, 1,680 shares of common stock were disposed of at $5.13 per share to satisfy tax withholding obligations tied to vesting restricted stock units (RSUs), rather than an open-market sale. After this withholding, Truong directly holds 305,417 shares of Enovix common stock, which includes 201,898 shares issuable upon vesting and settlement of RSUs and vested performance RSUs scheduled for release through March 2027 and April 2028.